FDA Investigator Kari M Laynor

Kari M Laynor has conducted inspections on 12 sites in 1 countries as of 22 Apr 2003. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
12
Last Inspection Date:
22 Apr 2003
Investigator Role:
FDA Investigation Participant
Redica ID:
100000932
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Kari M Laynor:
Andrea A Branche, Andrew B Bevill, Ariel Cruz Figueroa, Camerson E Moore, Charles I Ann, Christopher N Tran, Daniel J Lahar, Darla J Christopher, Dr. Jason R Caballero, Edward D Edmiston, Edwin Ramos, Ellen J Tave, Habacuc V Barrera, Hung V Le, J Elkins, Jocelyn C Turner, Jodi M Gatica, José E Meléndez, Jose Martinez, Jr, Kari M Johansen, Kevin T Nguyen, Lisa R Jennings, Lisa R Whitt, Margaret M Annes, Paula J Perry, Sha'tina R Alridge, Shawn E Larson, Sonia R Peterson, Stephen D Brown, Stephen L Beekman, Timothy H Vo, Torrance J Slayton, Tricia S Martinez, Tricia Y Samaniego, Uttaniti Limchumroon (Tom)

Kari M Laynor's Documents

Publish Date Document Type Title
November, 2001 FDA 483 Response The Dow Chemical Company - Form 483R, 2001-12-12
May, 2003 FDA 483 Professional Compounding Centers of America dba PCCA - Form 483, 2003-05-15
April, 2003 EIR Kavis Pharma LLC - EIR, 2003-04-10
May, 2002 EIR Proportional Technologies, Inc - EIR, 2002-05-07
January, 2000 FDA 483 Professional Compounding Centers of America dba PCCA - Form 483, 2000-01-25
December, 2002 FDA 483 Lee & Company - Form 483, 2002-12-13
August, 2000 FDA 483 Baxter-COMPASS - Form 483, 2000-08-11
March, 2002 FDA 483 Equalization Technologies, Inc - Form 483, 2002-03-08
December, 2000 FDA 483 Dixie Chemical Company - Form 483, 2000-12-15
September, 2002 EIR Nexgen Pharma, Inc. - EIR, 2002-09-16
October, 2000 FDA 483 Galveston Medical Supplies, Inc - Form 483, 2000-10-12
November, 2001 EIR The Dow Chemical Company - EIR, 2001-11-07
May, 2002 FDA 483 Proportional Technologies, Inc - Form 483, 2002-05-07
March, 2002 EIR United Labs, Inc - EIR, 2002-03-27
March, 2002 FDA 483 United Labs, Inc - Form 483, 2002-03-27
March, 2002 EIR Equalization Technologies, Inc - EIR, 2002-03-08
November, 2001 FDA 483 The Dow Chemical Company - Form 483, 2001-11-07

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more